{"id":6196,"date":"2026-02-09T17:21:36","date_gmt":"2026-02-09T14:21:36","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=6196"},"modified":"2026-02-09T17:21:38","modified_gmt":"2026-02-09T14:21:38","slug":"solid-biosciences-aligns-with-fda-on-sgt-003-phase-3-trial-design-for-duchenne-muscular-dystrophy-gene-therapy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/zh\/solid-biosciences-aligns-with-fda-on-sgt-003-phase-3-trial-design-for-duchenne-muscular-dystrophy-gene-therapy\/","title":{"rendered":"Solid Biosciences \u4e0e FDA \u5728\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u57fa\u56e0\u6cbb\u7597\u7684 SGT-003 III \u671f\u8bd5\u9a8c\u8bbe\u8ba1\u4e2d\u4fdd\u6301\u4e00\u81f4"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Solid Biosciences \u5ba3\u5e03\u4e86\u5176\u6700\u8fd1\u4e0e\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40 (FDA) \u4e3e\u884c\u7684 C \u7c7b\u4f1a\u8bae\u7684\u79ef\u6781\u76d1\u7ba1\u66f4\u65b0\uff0c\u8be5\u66f4\u65b0\u652f\u6301 SGT-003 \u4f5c\u4e3a\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u6f5c\u5728\u7597\u6cd5\u7684\u6301\u7eed\u63a8\u8fdb\u3002.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u5f71\u54cd\uff1a\u516c\u53f8\u4e0e FDA \u5408\u4f5c\u5f00\u5c55 3 \u671f\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u8bd5\u9a8c\u8bbe\u8ba1\u2014\u2014<\/li>\n\n\n\n<li>IMPACT DUCHENN\uff1a\u516c\u53f8\u9884\u8ba1\u5c06\u4e8e 2026 \u5e74\u7b2c\u4e00\u5b63\u5ea6\u8fdb\u884c\u9996\u6b21\u53d7\u8bd5\u8005\u7ed9\u836f\u2014\u2014<\/li>\n\n\n\n<li>\u516c\u53f8\u8ba1\u5212\u5728 2026 \u5e74\u4e0a\u534a\u5e74\u4e0e FDA \u4e3e\u884c\u66f4\u591a\u4f1a\u8bae\uff0c\u4ee5\u5c31 SGT-003 \u7684\u6f5c\u5728\u52a0\u901f\u5ba1\u6279\u9014\u5f84\u8fbe\u6210\u4e00\u81f4 \u2013<\/li>\n\n\n\n<li>INSPIRE DUCHENNE\uff1a\u622a\u81f32026\u5e742\u67089\u65e5\uff0c\u57281\/2\u671f\u8bd5\u9a8c\u4e2d\uff0cSGT-003\u7684\u8010\u53d7\u6027\u603b\u4f53\u826f\u597d\uff0c\u5171\u670936\u540d\u53d7\u8bd5\u8005\u63a5\u53d7\u4e86\u7ed9\u836f\u2014\u2014<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">FDA \u8ba4\u4e3a\u8be5\u8bd5\u9a8c\u8bbe\u8ba1\u5408\u7406\uff0c\u5305\u62ec\uff1a\u60a3\u8005\u4eba\u7fa4\u4e3a 7 \u81f3 &lt;12 \u5c81\u53ef\u884c\u8d70\u7684\u53c2\u4e0e\u8005\uff0c\u4e3b\u8981\u7ec8\u70b9\u4e3a 18 \u4e2a\u6708\u65f6\u4ece\u4ef0\u5367\u4f4d\u8d77\u7acb\u65f6\u95f4 (TTR) \u901f\u5ea6\u8f83\u57fa\u7ebf\u7684\u53d8\u5316\uff0c\u4ee5\u53ca\u5176\u4ed6\u5173\u952e\u6b21\u8981\u7ec8\u70b9\u3002.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u5173\u6ce8\u6b64\u9875\u9762<\/strong>&nbsp;&gt;&gt;&gt;&nbsp;<a href=\"https:\/\/dmdwarrior.com\/zh\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u6240\u6709\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u7684\u4e34\u5e8a\u8bd5\u9a8c<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Solid Biosciences announced a positive regulatory update from its recent Type C meeting with the U.S. Food and Drug Administration (FDA) that supports the continued advancement of SGT-003 as a potential treatment for Duchenne muscular dystrophy. The FDA agreed that the trial design was reasonable including: the patient population of ambulant participants 7 to &lt;12 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6197,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[88,110,170,109],"class_list":["post-6196","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-fda","tag-sgt-003","tag-sgt-003-gene-therapy","tag-solid-biosciences"],"subtitle":"Solid \u4e0e FDA \u5728\u516c\u53f8\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u7684 3 \u671f\u4e34\u5e8a\u8bd5\u9a8c IMPACT DUCHENN \u7684\u603b\u4f53\u7814\u7a76\u8bbe\u8ba1\u4e0a\u8fbe\u6210\u4e86\u4e00\u81f4\u3002.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/6196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/comments?post=6196"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/6196\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media\/6197"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media?parent=6196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/categories?post=6196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/tags?post=6196"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}